Northwest & Ethical Investments L.P. decreased its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 14.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,717 shares of the medical equipment provider's stock after selling 13,524 shares during the quarter. Northwest & Ethical Investments L.P. owned approximately 0.08% of STERIS worth $15,976,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Magnolia Capital Advisors LLC grew its position in STERIS by 1.9% during the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock worth $521,000 after buying an additional 48 shares in the last quarter. SkyView Investment Advisors LLC increased its holdings in STERIS by 1.6% in the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock valued at $765,000 after buying an additional 51 shares during the period. Park Edge Advisors LLC raised its position in shares of STERIS by 1.1% in the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock valued at $958,000 after buying an additional 51 shares in the last quarter. Citizens Financial Group Inc. RI lifted its holdings in shares of STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after acquiring an additional 54 shares during the period. Finally, Opal Wealth Advisors LLC boosted its position in shares of STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock worth $230,000 after acquiring an additional 60 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.
STERIS Price Performance
Shares of NYSE:STE traded up $2.61 during trading on Monday, hitting $223.03. 439,743 shares of the company were exchanged, compared to its average volume of 504,161. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a market capitalization of $21.91 billion, a P/E ratio of 47.35 and a beta of 0.92. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $221.02 and its 200-day moving average is $221.84.
STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.
STERIS Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS's dividend payout ratio (DPR) is presently 48.41%.
Analysts Set New Price Targets
STE has been the subject of several research analyst reports. JMP Securities restated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Stephens reissued an "overweight" rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $258.75.
Get Our Latest Stock Report on STE
STERIS Profile
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
See Also
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
